๐ŸŽ Black Friday: up to 50% off of annual plans
Community Health Systems, Inc. (CYH)
NYSE: CYH ยท Real-Time Price ยท USD
1.620
+0.010 (0.62%)
At close: Nov 20, 2026, 4:00 PM EST
1.630
+0.010 (0.62%)
After-hours: Nov 20, 2026, 7:30 PM EST

Community Health Systems Earnings Call Transcripts

Fiscal Year 2026

  • Persistent economic pressure and subsidy expirations shifted exchange patients to uninsured and delayed elective surgeries, weakening payer mix; Q4 seasonal recovery is expected below normal. Cost savings, ambulatory investment, physician recruitment and a debt exchange are key resilience measures.

  • Q3 adjusted EBITDA was $280M as uninsured care and deferred commercial procedures pressured results, while revenue and volumes grew. FY26 EBITDA and cash flow guidance were cut; cost actions, outpatient investment and potential deferred-volume recovery support the outlook.

  • Leadership is prioritizing quality, engagement, and ambulatory growth, with stable market share and a focus on capturing commercial elective volumes. Financial guidance was revised down due to payer mix and timing issues, but state-directed payments and cost controls provide some offset. AI and technology investments are improving workflows and physician satisfaction.

  • Q2 2026 saw lower EBITDA and net revenue due to reduced state payments, payer mix shifts, and higher uninsured volumes, despite operational improvements and cost controls. Guidance for 2026 was lowered, reflecting ongoing macroeconomic and ACA headwinds, with some offset from new Medicaid programs.

  • Indiana DPP approval and state programs are set to boost financials, while Q1 volumes were soft but expected to recover in H2. Labor costs have stabilized, physician retention is improving, and technology rollouts are enhancing efficiency and quality metrics.

  • Q1 2026 saw adjusted EBITDA decline 17.8% year-over-year due to divestitures and macro headwinds, but same-store net revenue rose 3.1%. Investments in ASCs and operational improvements position the company for a volume rebound in the second half, with 2026 guidance unchanged.

  • Management highlighted positive free cash flow, reduced leverage, and a focus on quality and operational efficiency. 2026 guidance projects revenue and EBITDA growth, with key variables including consumer confidence and regulatory changes. Ongoing cost controls, ERP and AI initiatives, and targeted capital investments support a positive outlook.

  • A new vision prioritizes quality, experience, and satisfaction, with formalized focus driving growth. Portfolio reshaping is nearly complete, leverage is targeted below 5.5x, and free cash flow remains positive. AI and ERP investments enhance efficiency, while capital shifts to outpatient and high-acuity services.

  • Leadership is focused on unified vision, quality, and cash flow, with 2026 guidance reflecting modest growth and stable denials. Asset sales are slowing, capital is shifting to outpatient expansion, and AI is being integrated across operations for efficiency.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021